Nifty

:

22302.50

Sensex

:

73511.85

-140.20 (-0.62%)
-383.69 (-0.52%)

Login

Nifty
Sensex

:
:

22302.50
73511.85

-140.20 (-0.62%)
-383.69 (-0.52%)

Aatmaj Healthcare Ltd.

Hospital & Healthcare Services

Rating :

50/99

BSE: Not Listed | NSE: AATMAJ

Watchlist

NSE BSE

36.55

07-May-2024

Open
High
Low
Previous Close

36.70
36.70
36.55
37.30

Volume
Traded Value (lacs)
52 Week High
52 Week Low

8000
2.93
60.00
31.10

Stock Summary

Market Cap(Crs)
Stock P:E
Face Value

82.60
16.79
5

Enterprise Value(Crs)
Dividend Yield
Price:Book Value

93.98
N/A
7.31

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

10 Years
5 Years
3 Years

-
-
-

EBITDA CAGR (%)

10 Years
5 Years
3 Years

-
-
-

PAT CAGR (%)

10 Years
5 Years
3 Years

-
-
-

P:E (Median)

8 Years
5 Years
3 Years

-
-
-

P:BV (Average)

8 Years
5 Years
3 Years

-
-
-

EV:EBITDA (Average)

8 Years
5 Years
3 Years

-
-
-

Quarterly Results

N/A

Annual Results

Standalone Figures in Rs. Crores /

Consolidated

Right to Left

Description TTM Mar 23 Mar 22
Net Sales - 27.16 21.81 Net Sales Growth - 24.53% Cost Of Goods Sold - 1.74 3.67 Gross Profit - 25.42 18.14 GP Margin - 93.59% 83.17% Total Expenditure - 17.33 14.30 Power & Fuel Cost - 0.20 0.18 % Of Sales - 0.74% 0.83% Employee Cost - 4.66 3.94 % Of Sales - 17.16% 18.07% Manufacturing Exp. - 4.35 3.62 % Of Sales - 16.02% 16.60% General & Admin Exp. - 6.36 2.85 % Of Sales - 23.42% 13.07% Selling & Distn. Exp. - 0.00 0.00 % Of Sales - 0% 0% Miscellaneous Exp. - 0.02 0.04 % Of Sales - 0.07% 0.18% EBITDA - 9.83 7.51 EBITDA Margin - 36.19% 34.43% Other Income - 0.03 0.00 Interest - 0.90 0.24 Depreciation - 0.69 0.43 PBT - 8.27 6.83 Tax - 2.37 1.78 Tax Rate - 28.66% 26.06% PAT - 5.91 5.05 PAT before Minority Interest - 5.91 5.05 Minority Interest - 0.00 0.00 PAT Margin - 21.76% 23.15% PAT Growth - 17.03% EPS - 2.62 2.23

Description TTM Mar 22
Net Sales - 21.81 Net Sales Growth - Cost Of Goods Sold - 4.02 Gross Profit - 17.79 GP Margin - 81.57% Total Expenditure - 14.29 Power & Fuel Cost - 0.18 % Of Sales - 0.83% Employee Cost - 3.94 % Of Sales - 18.07% Manufacturing Exp. - 2.95 % Of Sales - 13.53% General & Admin Exp. - 3.16 % Of Sales - 14.49% Selling & Distn. Exp. - 0.00 % Of Sales - 0% Miscellaneous Exp. - 0.04 % Of Sales - 0.18% EBITDA - 7.52 EBITDA Margin - 34.48% Other Income - 0.00 Interest - 0.24 Depreciation - 0.43 PBT - 6.85 Tax - 1.93 Tax Rate - 28.18% PAT - 4.92 PAT before Minority Interest - 4.92 Minority Interest - 0.00 PAT Margin - 22.56% PAT Growth - EPS - 2.18

Results Balance Sheet

Standalone Figures in Rs. Crores /

Consolidated

Right to Left

Description Mar 23 Mar 22
Shareholder's Funds 14.18 8.27 Share Capital 8.10 1.35 Total Reserves 6.08 6.92 Non-Current Liabilities 2.46 1.22 Secured Loans 0.79 0.00 Unsecured Loans 1.00 0.72 Long Term Provisions 0.00 0.00 Current Liabilities 14.37 7.98 Trade Payables 2.12 1.64 Other Current Liabilities 0.29 0.10 Short Term Borrowings 9.70 4.45 Short Term Provisions 2.25 1.79 Total Liabilities 31.01 17.47 Net Block 11.17 10.87 Gross Block 13.58 12.59 Accumulated Depreciation 2.41 1.72 Non Current Assets 11.17 10.88 Capital Work in Progress 0.00 0.00 Non Current Investment 0.00 0.00 Long Term Loans & Adv. 0.00 0.00 Other Non Current Assets 0.00 0.00 Current Assets 19.84 6.60 Current Investments 0.00 0.00 Inventories 0.40 0.41 Sundry Debtors 17.83 5.10 Cash & Bank 0.32 0.18 Other Current Assets 1.30 0.02 Short Term Loans & Adv. 1.26 0.89 Net Current Assets 5.47 -1.38 Total Assets 31.01 17.48

Description Mar 22
Shareholder's Funds 8.11 Share Capital 1.35 Total Reserves 6.76 Non-Current Liabilities 1.36 Secured Loans 0.00 Unsecured Loans 0.72 Long Term Provisions 0.00 Current Liabilities 7.72 Trade Payables 1.64 Other Current Liabilities 0.09 Short Term Borrowings 4.45 Short Term Provisions 1.54 Total Liabilities 17.19 Net Block 10.87 Gross Block 12.59 Accumulated Depreciation 1.72 Non Current Assets 11.13 Capital Work in Progress 0.00 Non Current Investment 0.00 Long Term Loans & Adv. 0.25 Other Non Current Assets 0.00 Current Assets 6.07 Current Investments 0.00 Inventories 0.41 Sundry Debtors 5.10 Cash & Bank 0.18 Other Current Assets 0.39 Short Term Loans & Adv. 0.39 Net Current Assets -1.66 Total Assets 17.20

Cash Flow

Standalone Figures in Rs. Crores /

Consolidated

Right to Left

Description Mar 23 Mar 22
Cash From Operating Activity 5.33 9.55 PBT 8.27 6.83 Adjustment 1.58 0.68 Changes in Working Capital -6.72 0.29 Cash after chg. in Working capital 3.14 7.80 Interest Paid 0.00 0.00 Tax Paid 2.19 1.75 Other Direct Exp. Paid 0.00 0.00 Extra & Other Items 0.00 0.00 Cash From Investing Activity -1.42 -3.37 Net Fixed Assets -0.99 Net Investments 0.00 Others -0.43 Cash from Financing Activity -3.78 -6.55 Net Cash Inflow / Outflow 0.14 -0.37 Opening Cash & Equivalents 0.18 0.55 Closing Cash & Equivalent 0.32 0.18

Description Mar 22
Cash From Operating Activity 2.25 PBT 6.85 Adjustment 0.68 Changes in Working Capital -3.52 Cash after chg. in Working capital 4.00 Interest Paid 0.00 Tax Paid -1.75 Other Direct Exp. Paid 0.00 Extra & Other Items 0.00 Cash From Investing Activity -3.22 Net Fixed Assets Net Investments Others Cash from Financing Activity 0.60 Net Cash Inflow / Outflow -0.37 Opening Cash & Equivalents 0.55 Closing Cash & Equivalent 0.18

Financial Ratios

Standalone /

Consolidated

Right to Left

Description Mar 23 Mar 22
Book Value (Rs.) 8.75 5.11 ROA 24.37% 37.04% ROE 52.62% 88.15% ROCE 46.63% 67.49% Fixed Asset Turnover 2.08 1.97 Receivable days 154.01 47.42 Inventory Days 5.41 5.10 Payable days 393.71 165.70 Cash Conversion Cycle -234.29 -113.18 Total Debt/Equity 0.83 0.63 Interest Cover 10.24 29.30

Description Mar 22
Book Value (Rs.) 5.00 ROA 28.62% ROE 60.70% ROCE 53.36% Fixed Asset Turnover 1.73 Receivable days 85.29 Inventory Days 6.78 Payable days 148.80 Cash Conversion Cycle -56.73 Total Debt/Equity 0.64 Interest Cover 29.35

Top Investors:

neomile corporate advisory limited

jayshree sanjay kolambekar

Annual Reports:

News Update:

No Latest News!

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.

Feedback